看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。- `5 \: ~2 N( J; D7 F5 u
2 [8 o) G+ X7 K0 d% w9 q$ _$ F
8 W4 o" b8 o9 h* d" Y* hCurrently available feasibility data for possible combination strategies.
1 v' v) p1 P7 w! B6 @) G————————————————————————————————
8 j( c; Y$ d c% ~" lCombination Feasibility according to preliminary data $ @, `- o5 }4 Y8 N. |9 x
——————————————————————————————————
/ w+ g. M) u2 [' j1 Q/ N! e$ GBevacizumab + sorafenib Yes, reduced dose
. H0 R/ q. Z- j# mBevacizumab + sunitinib† No
! `* D) k' g: [& {1 G% {' d1 w2 |Bevacizumab + temsirolimus Yes * I0 J1 c: s) B o
Bevacizumab + everolimus Yes
& A7 @; M* g7 p5 iSorafenib + sunitinib ? : q% g" {' j$ O# s' Q6 o; e
Sorafenib + temsirolimus Yes, reduced dose ! R5 f" [8 t0 X' |* s
Sorafenib + everolimus Yes, reduced dose # |0 r" A5 ^7 n8 }' O
Sunitinib + temsirolimus† No
- F) R' \7 V( N; ^Sunitinib + everolimus ? 4 Q7 y8 S! }4 a% ?/ g9 ?3 {
Temsirolimus + everolimus ? j. {4 T n1 V" ?" V
————————————————————, n: ?' z2 Y9 h" e6 ~
†Led to US FDA warning. [+ ` m; {( {0 u1 r
?: As yet unattempted combination.
# |' a. C- M1 W" g |